External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home EASL International Liver Congress 2021
Roche and Genentech at

EASL International Liver Congress 2021

June 23 - June 26
Virtual
congress-easl.com
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
10:00 AM
Duration 15mins Virtual
IMbrave150: exploratory efficacy and safety results of atezolizumab▼ + bevacizumab▼ vs sorafenib in patients with unresectable hepatocellular carcinoma (HCC) who had prior locoregional therapy (LRT)
Salem R, Galle PR, Finn R, Ducreux M, Singal AG, Nicholas A, Hernandez S, Verret W, Merle P, Zhu AX
Oncology | Hepatocellular Carcinoma

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.